Skip to Content

9,668 Results Found

  • Article
  • Open Access
11 Citations
4,738 Views
10 Pages

Health-Related Quality of Life and Survival in Metastasized Non-Small Cell Lung Cancer Patients with and without a Targetable Driver Mutation

  • Nicole E. Billingy,
  • Vashti N. M. F. Tromp,
  • Corina J. G. van den Hurk,
  • Annemarie Becker-Commissaris and
  • Iris Walraven

25 August 2021

Background: The aim of this study is to compare long-term health-related quality of life (HRQOL) and survival in metastatic NSCLC patients with (M+) and without (M−) a targetable driver mutation. Methods: An observational study was performed within t...

(This article belongs to the Special Issue Non-small Cell Lung Cancer with Targetable Driver Mutations)
  • Review
  • Open Access
46 Citations
8,238 Views
29 Pages

3 November 2020

The Raf murine sarcoma viral oncogene homolog B (BRAF) mutation is detected in 8–12% of metastatic colorectal cancers (mCRCs) and is strongly correlated with poor prognosis. The recent success of the BEACON CRC study and the development of targ...

  • Review
  • Open Access
30 Citations
8,084 Views
21 Pages

10 July 2021

Mutations in tumor suppressor gene TP53, encoding for the p53 protein, are the most ubiquitous genetic variation in human ovarian HGSC, the most prevalent and lethal histologic subtype of epithelial ovarian cancer (EOC). The majority of TP53 mutation...

(This article belongs to the Special Issue High-Grade Serous Ovarian Cancer)
  • Article
  • Open Access
25 Citations
5,508 Views
14 Pages

Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes

  • Otília Menyhart,
  • Tatsuhiko Kakisaka,
  • Lőrinc Sándor Pongor,
  • Hiroyuki Uetake and ,
  • Ajay Goel and
  • Balázs Győrffy
  • + 1 author+ 0 author

14 July 2019

Background: Numerous driver mutations have been identified in colorectal cancer (CRC), but their relevance to the development of targeted therapies remains elusive. The secondary effects of pathogenic driver mutations on downstream signaling pathways...

(This article belongs to the Special Issue New Biomarkers in Cancers)
  • Article
  • Open Access
1 Citations
643 Views
22 Pages

To accomplish underwater search missions of the target with stochastic motion, path planning is required prior to autonomous underwater vehicle (AUV) operations. Genetic algorithms (GAs) are a classical approach for target search path planning; howev...

(This article belongs to the Section Ocean Engineering)
  • Article
  • Open Access
105 Citations
11,989 Views
15 Pages

Monitoring of Target-Site Mutations Conferring Insecticide Resistance in Spodoptera frugiperda

  • Debora Boaventura,
  • Macarena Martin,
  • Alberto Pozzebon,
  • David Mota-Sanchez and
  • Ralf Nauen

18 August 2020

Fall armyworm (FAW), Spodoptera frugiperda, a major pest of corn and native to the Americas, recently invaded (sub)tropical regions worldwide. The intensive use of insecticides and the high adoption of crops expressing Bacillus thuringiensis (Bt) pro...

(This article belongs to the Special Issue Recent Advances in the Understanding of Molecular Mechanisms of Resistance in Noctuid Pests)
  • Article
  • Open Access
37 Citations
9,374 Views
16 Pages

Nanopore Targeted Sequencing for Rapid Gene Mutations Detection in Acute Myeloid Leukemia

  • Cosimo Cumbo,
  • Crescenzio Francesco Minervini,
  • Paola Orsini,
  • Luisa Anelli and ,
  • Antonella Zagaria,
  • Angela Minervini,
  • Nicoletta Coccaro,
  • Luciana Impera,
  • Giuseppina Tota and
  • Francesco Albano
  • + 10 authors+ 5 authors

9 December 2019

Acute myeloid leukemia (AML) clinical settings cannot do without molecular testing to confirm or rule out predictive biomarkers for prognostic stratification, in order to initiate or withhold targeted therapy. Next generation sequencing offers the ad...

(This article belongs to the Special Issue Genetics and Genomics of Acute Myeloid Leukemia)
  • Article
  • Open Access
5 Citations
4,109 Views
16 Pages

MET Mutation Is a Potential Therapeutic Target for Advanced Endometrial Cancer

  • Yu-Min Yeh,
  • Pei-Ying Wu,
  • Peng-Chan Lin,
  • Pei-Fang Su and ,
  • Ya-Ting Hsu,
  • Keng-Fu Hsu and
  • Meng-Ru Shen
  • + 2 authors+ 0 author

23 August 2021

An optimal therapeutic regimen for endometrial cancer with extra-uterine metastasis is unavailable. This study aims to improve our understanding of the genomic landscape of advanced endometrial cancer and identify potential therapeutic targets. The c...

  • Article
  • Open Access
1,398 Views
10 Pages

Targeted Biological Therapy and Germline Mutation Prevalence in Advanced Ovarian Cancer Patients

  • Anne-Marie Mosbæk Ellegaard,
  • Tim Svenstrup Poulsen and
  • Estrid Høgdall

16 December 2025

Background: Ovarian cancer is one of the most lethal gynecological malignancies, often diagnosed at an advanced stage. The prognosis is generally poor, with high recurrence rates and limited long-term survival. Understanding the genetic and molecular...

  • Review
  • Open Access
33 Citations
6,702 Views
16 Pages

31 July 2021

Basal cell carcinoma (BCC) is a significant public health concern, with more than 3 million cases occurring each year in the United States, and with an increasing incidence. The molecular basis of BCC is complex, involving an interplay of inherited g...

(This article belongs to the Special Issue Molecular Mechanisms of Skin Cancer)
  • Article
  • Open Access
8 Citations
3,936 Views
14 Pages

Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring EGFR Mutations

  • In Ae Kim,
  • Jae Young Hur,
  • Hee Joung Kim,
  • Song Am Lee and ,
  • Jae Joon Hwang,
  • Wan Seop Kim and
  • Kye Young Lee
  • + 2 authors+ 0 author

20 July 2021

Targeted NGS, widely applied to identify driver oncogenes in advanced lung adenocarcinoma, may also be applied to resected early stage cancers. We investigated resected EGFR-mutated lung adenocarcinoma mutation profiles to evaluate prognostic impacts...

(This article belongs to the Special Issue Biomarkers in Lung Cancer)
  • Review
  • Open Access
8 Citations
5,891 Views
27 Pages

Gliomas are the most common and lethal malignant primary brain tumors in adults, associated with the highest number of years of potential life lost. The latest WHO classification for central nervous system tumors highlighted the need for new biomarke...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
8 Citations
4,756 Views
12 Pages

24 March 2021

There are two combinations of heterozygous mutation, i.e., in trans, which carries mutations on different alleles, and in cis, which carries mutations on the same allele. Because only in trans compound heterozygous mutations have been implicated in a...

(This article belongs to the Section Medical Biology)
  • Article
  • Open Access
10 Citations
4,904 Views
12 Pages

Ghost-MTD: Moving Target Defense via Protocol Mutation for Mission-Critical Cloud Systems

  • Jun-Gyu Park,
  • Yangjae Lee,
  • Ki-Wan Kang,
  • Sang-Hoon Lee and
  • Ki-Woong Park

13 April 2020

Research on various security technologies has been actively underway to protect systems from attackers. However, attackers can secure enough time to reconnoiter and attack the target system owing to its static nature. This develops asymmetric warfare...

(This article belongs to the Section A1: Smart Grids and Microgrids)
  • Review
  • Open Access
26 Citations
6,353 Views
23 Pages

Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations

  • Pasquale Persico,
  • Elena Lorenzi,
  • Agnese Losurdo,
  • Angelo Dipasquale and ,
  • Antonio Di Muzio,
  • Pierina Navarria,
  • Federico Pessina,
  • Letterio Salvatore Politi,
  • Giuseppe Lombardi and
  • Matteo Simonelli
  • + 6 authors+ 1 author

22 February 2022

Mutations in isocitrate dehydrogenase (IDH)1 and its homolog IDH2 are considered an earliest “driver” genetic event during gliomagenesis, representing now the molecular hallmark of lower-grade gliomas (LGGs). IDH-mutated genes encode for...

(This article belongs to the Special Issue Meningiomas and Low Grade Gliomas)
  • Article
  • Open Access
3 Citations
5,030 Views
12 Pages

A Bioinformatic Pipeline for Monitoring of the Mutational Stability of Viral Drug Targets with Deep-Sequencing Technology

  • Yuri Kravatsky,
  • Vladimir Chechetkin,
  • Daria Fedoseeva,
  • Maria Gorbacheva and ,
  • Galina Kravatskaya,
  • Olga Kretova and
  • Nickolai Tchurikov
  • + 2 authors+ 0 author

23 November 2017

The efficient development of antiviral drugs, including efficient antiviral small interfering RNAs (siRNAs), requires continuous monitoring of the strict correspondence between a drug and the related highly variable viral DNA/RNA target(s). Deep sequ...

(This article belongs to the Special Issue Homage to Mark Wainberg)
  • Review
  • Open Access
43 Citations
11,216 Views
13 Pages

4 May 2023

Melanoma is the most common cause of death in skin cancer due to its high metastatic potential. While targeted therapies have improved the care of patients with metastatic melanoma harboring the BRAFV600E mutation, these treatments are associated wit...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
8 Citations
3,295 Views
16 Pages

This study aimed to determine the association between TMB and treatment outcomes in patients with epidermal growth factor receptor (EGFR)-mutated lung cancer that were treated with tyrosine kinase inhibitors (TKIs). The TMB was assessed using a 409-g...

(This article belongs to the Topic Targeting Signaling Networks for Cancer Therapy)
  • Article
  • Open Access
11 Citations
4,141 Views
15 Pages

21 November 2021

Herbicides that inhibit acetyl-CoA carboxylase (ACCase) are among the few remaining options for the post-emergence control of Lolium species in small grain cereal crops. Here, we determined the mechanism of resistance to ACCase herbicides in a Lolium...

(This article belongs to the Special Issue Molecular Mechanisms of Herbicide Resistance in Weeds)
  • Article
  • Open Access
21 Citations
5,242 Views
16 Pages

A Real-World Systematic Analysis of Driver Mutations’ Prevalence in Early- and Advanced-Stage NSCLC: Implications for Targeted Therapies in the Adjuvant Setting

  • Irene Terrenato,
  • Cristiana Ercolani,
  • Anna Di Benedetto,
  • Enzo Gallo and ,
  • Elisa Melucci,
  • Beatrice Casini,
  • Francesca Rollo,
  • Aldo Palange,
  • Paolo Visca and
  • Simonetta Buglioni
  • + 13 authors+ 8 authors

16 June 2022

The approval of osimertinib for adjuvant treatment of stage I–II–III EGFR-mutated NSCLC (early stage) represents a paradigm shift, raising the question of whether other genotype-matched therapeutics approved for advanced-stage NSCLC can a...

(This article belongs to the Special Issue Molecular Mechanisms of Lung Cancer and Mesothelioma)
  • Article
  • Open Access
7 Citations
4,669 Views
11 Pages

Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer Patients

  • Min-Ying Sun,
  • Fang-Qin Lin,
  • Lu-Jia Chen,
  • Hong Li and ,
  • Wei-Quan Lin,
  • Hong-Yan Du,
  • Xue-Xi Yang and
  • Ming Li
  • + 3 authors+ 0 author

24 June 2021

Liquid biopsy through the detection of circulating tumor DNA (ctDNA) has potential advantages in cancer monitoring and prediction. However, most previous studies in this area were performed with a few hotspot genes, single time point detection, or in...

(This article belongs to the Collection New Insights into Breast Cancer Diagnosis and Treatment)
  • Review
  • Open Access
5 Citations
2,700 Views
39 Pages

Advances in Targeting BCR-ABLT315I Mutation with Imatinib Derivatives and Hybrid Anti-Leukemic Molecules

  • Aleksandra Tuzikiewicz,
  • Wiktoria Wawrzyniak,
  • Andrzej Kutner and
  • Teresa Żołek

19 January 2026

Resistance to imatinib remains a therapeutic challenge, largely driven by point mutations within the kinase domain of the BCR-ABL, among which the T315I substitution constitutes the most clinically significant barrier. Ponatinib effectively inhibits...

(This article belongs to the Topic Imatinib (Glivec or Gleevec): Commemorative Topic in Honor of Dr. Jürg Zimmermann)
  • Article
  • Open Access
1 Citations
730 Views
36 Pages

31 December 2025

Target assignment is a core issue in command and control, aiming to rationally distribute targets among multiple coordinated operational units based on battlefield conditions to maximize overall operational effectiveness. This study proposes a target...

(This article belongs to the Section Aeronautics)
  • Article
  • Open Access
39 Citations
6,150 Views
18 Pages

24 February 2022

Background: Urothelial bladder carcinomas had traditionally been difficult to treat cancers, with high morbidity and mortality rates when invasive and metastatic. In recent years, immunotherapy with immune checkpoint inhibitors has improved outcomes...

(This article belongs to the Special Issue Current Advances in Clinical Genomics and Treatment of Urothelial Carcinoma)
  • Article
  • Open Access
5 Citations
3,787 Views
13 Pages

Insecticide Resistance and Target-Site Mutations kdr, N1575Y, and Ace-1 in Anopheles gambiae s.l. Populations in a Low-Malaria-Transmission Zone in the Sudanian Region of Senegal

  • Assiyatou Gueye,
  • El Hadji Malick Ngom,
  • Baye Bado Ndoye,
  • Mamadou Lamine Dione and ,
  • Babacar Diouf,
  • El Hadji Ndiaye,
  • Faty Amadou Sy,
  • Marième Guèye,
  • Makhtar Niang and
  • Ibrahima Dia
  • + 7 authors+ 2 authors

16 October 2024

Background/Objectives: Significant progress in malaria control has been achieved through long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), raising hopes for malaria elimination. However, emerging insecticide resistance threat...

(This article belongs to the Section Genes & Environments)
  • Article
  • Open Access
2 Citations
5,169 Views
18 Pages

Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene

  • Matthew Marr,
  • Anthony D’Abramo,
  • Nikea Pittman,
  • Mavis Agbandje-McKenna and ,
  • Susan Cotmore and
  • Peter Tattersall
  • + 1 author+ 0 author

30 January 2018

Combining virus-enhanced immunogenicity with direct delivery of immunomodulatory molecules would represent a novel treatment modality for melanoma, and would require development of new viral vectors capable of targeting melanoma cells preferentially....

(This article belongs to the Special Issue Protoparvoviruses: Friends or Foes?)
  • Article
  • Open Access
45 Citations
5,709 Views
17 Pages

13 July 2022

Fall armyworm (FAW), Spodoptera frugiperda, is an important lepidopteran pest in the Americas, and recently invaded the Eastern Hemisphere. In Brazil, FAW is considered the most destructive pest of corn and cotton. FAW has evolved resistance to many...

(This article belongs to the Special Issue The Evolution of Pesticide Resistance)
  • Article
  • Open Access
4 Citations
3,029 Views
17 Pages

17 April 2025

The Neotropical brown stink bug (NBSB), Euschistus heros, is the most prevalent sucking soybean pest in Brazil, and control of it largely relies on the application of synthetic insecticides such as ethiprole, a phenylpyrazole insecticide targeting GA...

(This article belongs to the Special Issue Chemical Toxicology and Insecticide Resistance on Insect Pests)
  • Review
  • Open Access
76 Citations
13,883 Views
16 Pages

HER2 in Non-Small Cell Lung Cancer: A Review of Emerging Therapies

  • Natalie F. Uy,
  • Cristina M. Merkhofer and
  • Christina S. Baik

27 August 2022

Human epidermal growth factor receptor 2 (HER2), a member of the ERBB family of tyrosine kinase receptors, has emerged as a therapeutic target of interest for non-small cell lung cancer (NSCLC) in recent years. Activating HER2 alterations in NSCLC in...

(This article belongs to the Special Issue Actionable Mutations in Lung Cancer)
  • Review
  • Open Access
92 Citations
14,685 Views
19 Pages

Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants

  • Zahra Hajiahmadi,
  • Ali Movahedi,
  • Hui Wei,
  • Dawei Li and ,
  • Yasin Orooji,
  • Honghua Ruan and
  • Qiang Zhuge
  • + 2 authors+ 0 author

The CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeat-associated protein 9) is a powerful genome-editing tool in animals, plants, and humans. This system has some advantages, such as a high on-target mutation rate (targetin...

(This article belongs to the Special Issue Genome Editing in Plants)
  • Review
  • Open Access
42 Citations
5,900 Views
14 Pages

Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments

  • Marine Valery,
  • Damien Vasseur,
  • Francesco Fachinetti,
  • Alice Boilève and ,
  • Cristina Smolenschi,
  • Anthony Tarabay,
  • Leony Antoun,
  • Audrey Perret,
  • Alina Fuerea and
  • Michel Ducreux
  • + 8 authors+ 3 authors

6 September 2023

Biliary tract cancers (BTCs) are rare tumours, most often diagnosed at an unresectable stage, associated with poor prognosis, with a 5-year survival rate not exceeding 10%. Only first- and second-line treatments are well codified with the combination...

(This article belongs to the Collection Treatment of Hepatocellular Carcinoma and Cholangiocarcinoma)
  • Article
  • Open Access
7 Citations
5,577 Views
14 Pages

Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients

  • Fabio Canino,
  • Antonio Tornincasa,
  • Stefania Bettelli,
  • Samantha Manfredini and ,
  • Monica Barbolini,
  • Luca Moscetti,
  • Claudia Omarini,
  • Angela Toss,
  • Fabio Tamburrano and
  • Federico Piacentini
  • + 12 authors+ 7 authors

20 February 2024

Over the last two decades, the use of Next-Generation Sequencing (NGS) in medical oncology has increased the likelihood of identifying druggable mutations that may be potentially susceptible to targeted treatments. The European Society for Medical On...

(This article belongs to the Special Issue Molecular Basis and Advances of Targeted Therapy for Breast Cancer)
  • Article
  • Open Access
4 Citations
3,738 Views
14 Pages

Discovery of Novel Potential Prognostic Markers and Targeted Therapy to Overcome Chemotherapy Resistance in an Advanced-Stage Wilms Tumor

  • Pongsakorn Choochuen,
  • Natakorn Nokchan,
  • Natthapon Khongcharoen,
  • Wison Laochareonsuk and ,
  • Komwit Surachat,
  • Thirachit Chotsampancharoen,
  • Thanit Sila and
  • Surasak Sangkhathat
  • + 3 authors+ 0 author

19 April 2024

Wilms tumor (WT), the most prevalent type of renal cancer in children, exhibits overall survival rates exceeding 90%. However, chemotherapy resistance, which occurs in approximately 10% of WT cases, is a major challenge for the treatment of WT, parti...

(This article belongs to the Section Cancer Biomarkers)
  • Review
  • Open Access
116 Citations
15,682 Views
37 Pages

15 February 2021

Due to groundbreaking developments and continuous progress, the treatment of advanced and metastatic non-small cell lung cancer (NSCLC) has become an exciting, but increasingly challenging task. This applies, in particular, to the subgroup of NSCLC w...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
5 Citations
3,423 Views
20 Pages

Translational Insights in the Landscape of Salivary Gland Cancers: Ready for a New Era?

  • Francesco Perri,
  • Roberta Fusco,
  • Francesco Sabbatino,
  • Morena Fasano and ,
  • Alessandro Ottaiano,
  • Marco Cascella,
  • Maria Luisa Marciano,
  • Monica Pontone,
  • Giovanni Salzano and
  • Franco Ionna
  • + 13 authors+ 8 authors

28 February 2024

Salivary gland carcinomas (SGCs) are rare neoplasms, representing less than 10% of all head and neck tumors, but they are extremely heterogeneous from the histological point of view, their clinical behavior, and their genetics. The guidelines regardi...

(This article belongs to the Special Issue Novel Therapeutic Strategies in Salivary Gland Tumor)
  • Article
  • Open Access
3 Citations
2,890 Views
13 Pages

Benefits of NGS in Advanced Lung Adenocarcinoma Vary by Populations and Timing of Examination

  • Po-Hsin Lee,
  • Wei-Fan Ou,
  • Yen-Hsiang Huang,
  • Kuo-Hsuan Hsu and ,
  • Jeng-Sen Tseng,
  • Gee-Chen Chang and
  • Tsung-Ying Yang
  • + 2 authors+ 0 author

Despite the widespread application of next-generation sequencing (NGS) in advanced lung adenocarcinoma, its impact on survival and the optimal timing for the examination remain uncertain. This cohort study included advanced lung adenocarcinoma patien...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
29 Citations
6,335 Views
12 Pages

Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis

  • Kun-Ming Rau,
  • Han-Ku Chen,
  • Li-Yen Shiu,
  • Tsai-Ling Chao and ,
  • Yi-Ping Lo,
  • Chin-Chou Wang,
  • Meng-Chih Lin and
  • Chao-Cheng Huang
  • + 3 authors+ 0 author

Mutations on epidermal growth factor receptor (EGFR) of adenocarcinomas of lung have been found to be associated with increased sensitivity to EGFR tyrosine kinase inhibitors and K-ras mutations may correlate with primary resistance. We aimed to expl...

(This article belongs to the Special Issue Brain Metastasis 2016)
  • Article
  • Open Access
6 Citations
4,434 Views
20 Pages

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders

  • Luca Pagliaro,
  • Elisa Cerretani,
  • Federica Vento,
  • Anna Montanaro and ,
  • Lucas Moron Dalla Tor,
  • Elisa Simoncini,
  • Mariateresa Giaimo,
  • Andrea Gherli,
  • Raffaella Zamponi and
  • Giovanni Roti
  • + 15 authors+ 10 authors

NOTCH1 PEST domain mutations are often seen in hematopoietic malignancies, including T-cell acute lymphoblastic leukemia (T-ALL), chronic lymphocytic leukemia (CLL), splenic marginal zone lymphoma (SMZL), mantle cell lymphoma (MCL), and diffuse large...

(This article belongs to the Special Issue Pathophysiology to Novel Therapeutic Approaches for Leukemia)
  • Review
  • Open Access
170 Citations
14,873 Views
30 Pages

BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers

  • Giorgia Castellani,
  • Mariachiara Buccarelli,
  • Maria Beatrice Arasi,
  • Stefania Rossi and ,
  • Maria Elena Pisanu,
  • Maria Bellenghi,
  • Carla Lintas and
  • Claudio Tabolacci
  • + 3 authors+ 0 author

8 August 2023

Melanoma is an aggressive form of skin cancer resulting from the malignant transformation of melanocytes. Recent therapeutic approaches, including targeted therapy and immunotherapy, have improved the prognosis and outcome of melanoma patients. BRAF...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
3 Citations
5,956 Views
14 Pages

Molecular Profiling of Nasopharyngeal Carcinoma Using the AACR Project GENIE Repository

  • Beau Hsia,
  • Asritha Sure,
  • Roshan Dongre,
  • Nicolas Jo and ,
  • Julia Kuzniar,
  • Gabriel Bitar,
  • Saif A. Alshaka,
  • Jeeho D. Kim,
  • Bastien A. Valencia-Sanchez and
  • Vijay A. Patel
  • + 10 authors+ 5 authors

1 May 2025

Background: Nasopharyngeal carcinoma (NPC) is a rare head and neck cancer arising from the mucosal lining of the nasopharynx, for which systemic therapeutic options remain scarce, reflecting the limited characterization of its genomic profile. This s...

(This article belongs to the Section Molecular Cancer Biology)
  • Review
  • Open Access
5 Citations
5,148 Views
21 Pages

Unmet Horizons: Assessing the Challenges in the Treatment of TP53-Mutated Acute Myeloid Leukemia

  • Christos Stafylidis,
  • Dimitra Vlachopoulou,
  • Christina-Nefeli Kontandreopoulou and
  • Panagiotis Τ. Diamantopoulos

14 February 2024

Acute myeloid leukemia (AML) remains a challenging hematologic malignancy. The presence of TP53 mutations in AML poses a therapeutic challenge, considering that standard treatments face significant setbacks in achieving meaningful responses. There is...

(This article belongs to the Special Issue Acute Myeloid Leukemia: Latest Advances in the Diagnostics, Therapeutic Strategies and Clinical Management)
  • Review
  • Open Access
16 Citations
5,811 Views
28 Pages

Molecular targeted therapy has been reported to have fewer adverse effects, and offer a more convenient route of administration, compared with conventional chemotherapy. With the development of sequencing technology, and research on the molecular bio...

(This article belongs to the Special Issue Protein Kinase Inhibitors for Targeted Anticancer Therapies)
  • Article
  • Open Access
18 Citations
4,265 Views
12 Pages

TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro

  • Julie Delyon,
  • Anaïs Vallet,
  • Mélanie Bernard-Cacciarella,
  • Isabelle Kuzniak and ,
  • Coralie Reger de Moura,
  • Baptiste Louveau,
  • Fanélie Jouenne,
  • Samia Mourah,
  • Céleste Lebbé and
  • Nicolas Dumaz
  • + 5 authors+ 0 author

24 May 2023

Because BRAF-mutated melanomas are addicted to the Mitogen Activated Protein Kinase (MAPK) pathway they show a high response rate to BRAF and MEK inhibitors. However, the clinical responses to these inhibitors are often short-lived with the rapid ons...

(This article belongs to the Special Issue Latest Development in Melanoma Research)
  • Review
  • Open Access
84 Citations
11,722 Views
21 Pages

Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives

  • Michela Croce,
  • Silvano Ferrini,
  • Ulrich Pfeffer and
  • Rosaria Gangemi

18 June 2019

Among Uveal Melanoma (UM) driver mutations, those involving GNAQ or GNA11 genes are the most frequent, while a minor fraction of tumors bears mutations in the PLCB4 or CYSLTR2 genes. Direct inhibition of constitutively active oncoproteins deriving fr...

(This article belongs to the Special Issue Uveal Melanoma)
  • Article
  • Open Access
13 Citations
4,249 Views
12 Pages

Novel Pathogenic Mutations Identified from Whole-Genome Sequencing in Unsolved Cases of Patients Affected with Inherited Retinal Diseases

  • Hafiz Muhammad Jafar Hussain,
  • Meng Wang,
  • Austin Huang,
  • Ryan Schmidt and ,
  • Xinye Qian,
  • Paul Yang,
  • Molly Marra,
  • Yumei Li,
  • Mark E. Pennesi and
  • Rui Chen
  • + 5 authors+ 0 author

9 February 2023

Inherited retinal diseases (IRDs) are a diverse set of visual disorders that collectively represent a major cause of early-onset blindness. With the reduction in sequencing costs in recent years, whole-genome sequencing (WGS) is being used more frequ...

(This article belongs to the Special Issue Feature Papers in Human Genomics and Genetic Diseases)
  • Review
  • Open Access
50 Citations
8,290 Views
16 Pages

MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies

  • Solange Rivas,
  • Arnaldo Marín,
  • Suraj Samtani,
  • Evelin González-Feliú and
  • Ricardo Armisén

11 November 2022

The MET gene, known as MET proto-oncogene receptor tyrosine kinase, was first identified to induce tumor cell migration, invasion, and proliferation/survival through canonical RAS-CDC42-PAK-Rho kinase, RAS-MAPK, PI3K-AKT-mTOR, and β-catenin sign...

(This article belongs to the Special Issue State-of-the-Art Molecular Oncology in Chile)
  • Article
  • Open Access
7 Citations
4,148 Views
12 Pages

Genomic Characterization of Chordoma: Insights from the AACR Project GENIE Database

  • Beau Hsia,
  • Gabriel Bitar,
  • Saif A. Alshaka,
  • Jeeho D. Kim and ,
  • Bastien A. Valencia-Sanchez,
  • Farhoud Faraji,
  • Michael G. Brandel,
  • Mariko Sato,
  • John Ross Crawford and
  • Sean P. Polster
  • + 7 authors+ 2 authors

5 February 2025

Background: Chordoma is a rare primary tumor originating from embryonic notochord remnants, with limited systemic therapeutic options due to a poor understanding of its genomic landscape. This study aims to characterize the genetic alterations in cho...

(This article belongs to the Section Cancer Informatics and Big Data)
  • Article
  • Open Access
1 Citations
2,371 Views
10 Pages

Analysis of the Occurrence of PIK3CA Gene Mutation in Children with Lymphatic Malformation—Single Center Study

  • Justyna Kukulska,
  • Elżbieta Sałacińska-Łoś,
  • Ewelina Perdas and
  • Przemysław Przewratil

28 October 2025

Background: Lymphatic malformations (LM) are rare congenital vascular anomalies caused by abnormal development and growth of lymphatic vessels. These malformations can lead to a wide range of symptoms, from mild swelling to more severe complications....

(This article belongs to the Section Translational Pediatrics)
  • Article
  • Open Access
9 Citations
4,868 Views
11 Pages

miRNA Mediated Noise Making of 3′UTR Mutations in Cancer

  • Wei Wu,
  • Lingxiang Wu,
  • Mengyan Zhu,
  • Ziyu Wang and ,
  • Min Wu,
  • Pengping Li,
  • Yumin Nie,
  • Xue Lin,
  • Jie Hu and
  • Sali Lyu
  • + 8 authors+ 3 authors

12 November 2018

Somatic mutations in 3′-untranslated regions (3′UTR) do not alter amino acids and are considered to be silent in cancers. We found that such mutations can promote tumor progression by altering microRNA (miRNA) targeting efficiency and con...

(This article belongs to the Special Issue Non-coding RNAs)
  • Review
  • Open Access
14 Citations
6,977 Views
27 Pages

Braf-Mutant Melanomas: Biology and Therapy

  • Elvira Pelosi,
  • Germana Castelli and
  • Ugo Testa

3 December 2024

The incidence of melanoma, the most lethal form of skin cancer, has increased mainly due to ultraviolet exposure. The molecular characterization of melanomas has shown a high mutational burden led to the identification of some recurrent genetic alter...

of 194